Skip to main content

A pilot study of the impact of an exercise intervention on brain structure, cognition, and psychosocial symptoms in individuals with relapsing-remitting multiple sclerosis

Abstract

Background

Despite pharmacological treatment, many individuals with multiple sclerosis (MS) continue to experience symptoms and medication side effects. Exercise holds promise for MS, but changes in brain structure following exercise have not been thoroughly investigated, and important cognitive and psychosocial variables are rarely primary outcomes. The aim of this pilot study was to investigate whether a 12-week exercise intervention would improve white matter integrity in the brain, or cognition, symptoms of fatigue, and depressed mood for individuals with relapsing-remitting MS (RRMS).

Method

Thirteen participants completed 12 weeks of speeded walking. Baseline and post-intervention testing included 3T diffusion tensor imaging (DTI) to assess white matter and neuropsychological testing to assess cognition, fatigue, and mood. Image pre-processing and analyses were performed in functional magnetic resonance imaging of the Brain Software Library.

Results

Post-intervention, there were no significant changes in white matter compared to baseline. Post-intervention, individuals with RRMS performed significantly better on the Symbol Digit Modalities Test (SDMT), reported fewer perceived memory problems, and endorsed less fatigue. Performance was not significantly different on Trails or Digit Span, and there were no significant changes in reports of mood.

Conclusion

Although 12 weeks of speeded walking did not improve white matter integrity, exercise may hold promise for managing some symptoms of RRMS in the context of this study population.

Peer Review reports

Feasibility

What uncertainties existed regarding the feasibility?

  • Would individuals with RRMS who meet the study’s eligibility criteria be able to complete a 12-week exercise intervention?

  • Given the lack of exercise interventions in MS that include brain imaging as an outcome measure, can a novel brain imaging method (such as DTI) be used to examine white matter microstructure pre- and post-exercise?

What are the key feasibility findings?

  • Eligible individuals with RRMS were able to complete the 12-week exercise intervention, with a mean adherence of 98.29%.

  • DTI data was acquired pre- and post-intervention for 13 participants. Microstructural white matter alterations in the brain were not detected post-intervention using DTI, but imaging findings may be limited by a small sample size. Additionally, functional brain changes were not examined in the current study.

What are the implications of the feasibility findings for the design of the future study?

  • It was feasible for individuals with RRMS who met the study’s eligibility criteria to complete the 12-week exercise intervention.

  • Future studies with larger sample sizes that employ a multi-modal imaging approach (e.g., include functional MRI alongside DTI) may further clarify the extent to which DTI is an effective means of tracking the efficacy of exercise interventions for individuals with RRMS. Multi-modal imaging approaches would also provide additional information about functional changes in the brain.

Background

Multiple sclerosis (MS) is a chronic inflammatory disease characterized by focal white matter degeneration and changes in gray matter volume. Given that the lesions associated with MS can be distributed throughout the central nervous system, individuals with MS often experience a constellation of sensory, motor, and cognitive symptoms, as well as issues with fatigue and mood [1]. Because there is currently no cure for MS, and individuals are typically diagnosed in early adulthood, most individuals require treatment for the majority of their lives [2]. Pharmaceuticals are often prescribed for long-term medical management, but these are costly and have variable effectiveness with possible unwanted side effects [3, 4]. Thus, there is a critical need for the implementation of low-cost and side effect-free behavioral interventions to help with symptom management.

In addition to medical management, exercise holds promise for individuals with MS. Exercise has shown benefits in the prevention of cognitive decline in aging populations [5] and in the management of other types of neurological disorders, such as Parkinson’s disease and Alzheimer’s disease [6, 7]. Importantly, exercise interventions can be accessible (e.g., can be completed without expensive equipment; available to diverse socioeconomic populations) and are non-invasive [8].

To date, several reviews and meta-analyses have looked at the clinical impact of exercise interventions for individuals with MS. These studies have provided early evidence that exercise interventions have modest effects on improving some MS symptoms [9, 10]; however, the primary outcomes of these studies have largely been confined to physical measures (e.g., walking, strength, mobility). There is preliminary evidence that exercise may contribute to small improvements in cognition [11], fatigue [8, 12], and mood [13], but these cognitive and psychosocial variables were often not the primary outcome measures.

Currently, a significant limitation in the literature relates to the lack of investigations on changes in brain structure that may result from exercise interventions and relate to improved symptoms of MS. Indeed, the use of neuroimaging techniques, such as magnetic resonance imaging (MRI), to examine the neural effects of exercise in individuals with MS has been identified as a major gap in the literature [14, 15]. MRI is a non-invasive, safely repeatable technique that allows for the examination of brain structure and is typically used in the assessment and diagnosis of MS [16]. One landmark study performed by Leavitt and colleagues [17] found that the 12-week stationary cycling (3 times per week) contributed to the increased hippocampal volumes, increased resting-state functional connectivity, and improved memory performance.

To date, very few studies have examined diffusion tensor imaging (DTI) metrics pre-post exercise intervention. DTI is a type of MRI scan that measures water diffusion in the brain to provide indices of white matter integrity [18, 19]. DTI’s sensitivity to detect microstructural characteristics of white matter makes it an ideal tool to examine possible neuroprotective effects of exercise on individuals with MS [20].

In preparation for a larger study, the goal of this pilot study was to examine whether the implementation of a 12-week speeded walking exercise intervention would improve white matter integrity (as measured by DTI), cognition, or symptoms of fatigue and depressed mood for individuals with relapsing-remitting MS (RRMS). Secondary objectives were related to the feasibility of the pilot trial (e.g., would eligible individuals with RRMS complete the exercise intervention? Can DTI be used to examine white matter microstructure pre- and post-exercise?)

Methods

Recruitment

Participants were recruited from the local health authority’s permission to contact program. The permission to contact program connects eligible researchers with individuals who have declared an interest in participating in research. Interested participants contacted the research team via telephone or email, and they were assessed for eligibility. Based on the largest sample available within both funding and access to MRI constraints, 16 individuals were recruited

Sample size

Sample size was based on the largest sample available both within funding and access to MRI constraints and is consistent with than previous MRI-based intervention studies involving individuals with MS [17, 27].

Participants

Participants were eligible if they were diagnosed with RRMS, at least 19 years of age, fluent in English, able to walk without assistance or rest for at least 300 m (consistent with Expanded Disability Status Scale score of 4.5 or less), and able to complete study tasks (e.g., exercise intervention, neuropsychological testing) independently. Exclusion criteria included having any MRI contraindications (e.g., metal implants, pacemakers), claustrophobia, and any comorbid neurological disorders. All participants attended pre- and post-intervention MRI and interview appointments, where neuroimaging, neuropsychological testing, and self-report measures were completed.

Imaging data acquisition

DTI data were collected by a trained MRI technician with one of the study team members present at West Coast Medical Imaging (Victoria, BC) on a 3T GE Signa Pioneer MRI scanner pre- and post-intervention. The images were acquired with an EPI sequence, axially, with the following parameters: TR = 8000 ms, TE = 101 ms, flip angle = 90, 52 slices, voxel size = 1.4 × 1.4 × 2.0 mm. There were 48 images acquired for each scan: 45 diffusion-weighted images (b = 1000 s/mm2) and 3 non-diffusion-weighted images (b = 0 s/mm2). The acquisition took approximately 6 min.

Neuropsychological testing and self-report measures

Appointments took place at the University of Victoria. Neuropsychological and self-report measures were administered by a trained graduate student in clinical neuropsychology. Pre- and post-intervention neuropsychological testing was conducted using the Symbol Digit Modalities Test (SDMT) [21], Trail Making Test [22], and Digit Span [23] to assess cognition. Participants also completed pre- and post-intervention self-report measures to assess perceived cognitive impairment (attention/concentration, retrospective memory, prospective memory, and planning/organization; Perceived Deficit Questionnaire; PDQ) [24] fatigue (Modified Fatigue Impact Scale; MFIS) [24, 25], and mood (Beck Depression Inventory 2nd edition, BDI-II) [26].

Speeded walking intervention

The exercise intervention, based on a treadmill walking intervention in a previous pilot trial [27], involved independent speeded walking three times per week at increasing intervals (15 to 35 min) over the course of 12 weeks (36 sessions total). Participants wore activity monitors (Fitbits) to time their sessions, ensure they were reaching a target heart rate zone of at least 50% of maximum predicted heart rate, and encourage adherence. They also logged their walking activity on an exercise tracking form provided to them. Participants were asked not to stop any consistent exercise (e.g., weekly class) in which they were already engaged, nor begin any new exercise that was unrelated to the study. Individuals with MS were not receiving any concurrent physiotherapy during the study period. Participants were asked to report any adverse events to the study team.

Data analyses

Changes in DTI metrics (fractional anisotropy; FA, mean diffusivity; MD, axial diffusivity; AD, and radial diffusivity; RD), neuropsychological performance, and MS symptoms from pre- to post-intervention were examined. Image pre-processing and analysis was performed using FMRIB Software Library [28]. Eddy Correct was used to correct for eddy current distortions and head movement. Next, brain extraction tool was used to remove the non-brain tissue, and then, brain-extracted images were visually inspected to confirm only non-brain tissue was removed [29]. FA maps were generated using DTIfit and input into Tract-Based Spatial Statistics (TBSS) [30], followed by randomise with threshold-free cluster enhancement. This was repeated for MD, AD, and RD.

Non-imaging group-level demographic and inferential statistical analyses were performed in R Studio. The assumption of normality was assessed using the Shapiro-Wilk test. Deviations from normality were observed for Trails A (W=.793, p=.006), Trails B (W=.866, p=.046), Digit Span (W=.825, p=.014), BDI-II (W=.865, p=.045), PDQPlanning&Organization (W=.822, p=.013), but not for SDMT (W=.921, p =.257), MFIS (W=.983, p=.990), PDQ (W=.930, p = .341), PDQAttention (W= .974, p = .939), PDQProspectiveMemory (W =.912, p = .194), PDQRetrospectiveMemory (W=.879, p =0.068). Thus, non-parametric Wilcoxon signed-rank tests (Trails A, Trails B, Digit Span, BDI-II, and PDQPlanning&Organization) and parametric paired Student t tests (SDMT, MFIS, PDQ, PDQAttention, and PDQProspectiveMemory, PDQRetrospectiveMemory) and were used to compare post-intervention scores to pre-intervention scores on neuropsychological tests and self-report measures. Corresponding 95% confidence intervals were also calculated for mean paired differences (paired sample t tests) and Hodges-Lehmann Estimate (Wilcoxon signed-rank tests). Normed (for age, education, and sex where available) neuropsychological test scores were used.

Results

Participants

Sixteen individuals with RRMS were recruited for the study, but three individuals withdrew prior to study completion. Remaining participants included 10 females and 3 males with RRMS (mean age= 58.76 ± 11.07 years). Please see Table 1 for further demographic information. One female’s imaging data was omitted from the DTI analysis due to missing post-intervention scans. Recruitment occurred in June 2018. Data collection took place from August 2018 to November 2018. Participants adherence was 98.29% (mean sessions completed = 35.38 ± 0.77 out of a total of 36 sessions). No adverse events were reported to the study team.

Table 1 Participant demographics

DTI

Post-intervention there were no significant changes in any of the DTI metrics, including FA, MD, AD, or RD (p<0.05, corrected for multiple comparisons), compared to baseline. Extracted mean FA, MD, AD, and RD values are reported in Table 2.

Table 2 Pre- and post-intervention DTI metrics, including mean fractional anisotropy (FA), and mean, axial, and radial diffusivity (MD; AX; RD; mm2/s)

Cognition, fatigue, and mood

Post-intervention, individuals with RRMS performed significantly better on the SDMT. Additionally, individuals with RRMS perceived fewer prospective memory problems (PDQ) and reported fewer symptoms of fatigue (MFIS) compared to pre-intervention (Table 3).

Table 3 Pre- and post-intervention performance on neuropsychological tests and self-report measures

Post-intervention performance on Trails A, Trails B, and Digit Span was not significantly different than pre-intervention performance. There were also no significant changes in reports perceived problems with attention, retrospective memory, or planning (PDQ) or mood (BDI-II) post-intervention compared to pre-intervention (See Table 3).

Discussion

This study investigated whether 12 weeks of speeded walking would significantly improve white matter integrity in the brain, cognition, or symptoms of fatigue and depressed mood for individuals with RRMS. It also examined the feasibility of the current pilot trial to be expanded for a future study. Following 12 weeks of speeded walking, individuals with RRMS performed better on a cognitive measure involving processing speed, reported fewer perceived prospective memory problems and significantly less fatigue. There were no changes in white matter integrity, as measured by DTI. Overall, it was feasible for individuals with RRMS to complete the 12-week exercise intervention with excellent adherence. There were also no adverse events reported.

Brain changes

MS is characterized by demyelination and degeneration of axons, and the use is MRI is integral in clinical assessment and diagnosis [16, 31]. The current pilot study did not observe any white matter changes in individuals with RRMS following 12 weeks of speeded walking, as assessed using DTI. Although there were not significant improvements in white matter integrity, there were also no significant declines in white matter integrity, as may be expected in a demyelinating disorder such as MS [31]. Indeed, several studies have observed longitudinal changes in DTI metrics in individuals with MS. Ontaneda and colleagues [32] observed significant increases in AD in enhancing and chronic lesions over 4 years of follow-up. Additionally, Kolasa and colleagues [33] found increases in FA and AD and decreases in RD in regions of the corpus callosum over 4 years of follow-up.

Changes in brain structure and function following exercise interventions, specifically, have not yet been thoroughly investigated in individuals with MS [15]. Although there have only been a few pilot trials [17, 27] even fewer have used DTI. Recently, Tavazzi and colleagues [34] used TBSS, among other imaging measures, to assess any differences in DTI metrics in 29 individuals following 4 weeks of rehabilitation exercises for MS that involved resistance or endurance training. Similar to our findings, there were no changes in any DTI metrics. Interestingly, they observed increased functional connectivity in the precentral and post-central gyrus at the end of the 4 weeks, but these findings did not hold at a second follow-up 3 months later. Future research in this area would benefit from the use of multi-modal imaging approaches, including functional MRI, DTI, and other structural imaging methods (e.g., T1 and FLAIR scan), to gain a more complete understanding of possible changes in the brain resulting from exercise intervention.

Cognition

Up to 70% of individuals with MS experience reductions in cognition, especially for tasks that involve information processing, executive function, and memory [35,36,37]. The current study found that individuals with RRMS performed significantly better on the SDMT following 12 weeks of speeded walking, but not Trails or Digit Span. The SDMT is considered the measure of choice for MS as it has shown to be sensitive to declines in cognition observed in MS and has correlated well with other measures of disease progression, such as atrophy and lesion burden [38, 39]. To date there are mixed findings on the impact of exercise on cognition in MS [11]; while some studies have found exercise improved performance on the SDMT [40] other studies have found no such relationship [17, 41]. As in other psychosocial outcomes, this heterogeneity is possibly attributed to methodological issues, such as diversity in exercise interventions, and cognition not included as a primary outcome [11].

Fatigue

Fatigue is among the most commonly reported symptoms of MS [42, 43]. The current study found that individuals reported significantly less fatigue after 12 weeks of speeded walking. This result is consistent with findings from other meta-analyses [12]. It is possible that exercise decreases pro-inflammatory cytokines, which are thought to be related to fatigue [6, 44]. Still, there is heterogeneity in findings, perhaps due to the variability in exercise interventions, ranging from endurance to strength training to mixed methods as well as fatigue being included as a secondary outcome measure [8].

Mood

Low mood is a common symptom of MS, and up to 50% of individuals diagnosed with MS have experienced depression at some point in their lifetime [45, 46]. The current study did not find evidence for significant reductions in reports of depressed mood following 12 weeks of speeded walking. However, it is important to consider that this result may be particular to our study given that at baseline, the majority of participants reported minimal symptoms of depression. It is possible that the impact of exercise on mood may only be evident in individuals with more severe levels of depression. For example, in a meta-analysis, Dalgas and colleagues [13] found that the studies that demonstrated positive impacts of exercise on mood in MS had participants with higher baseline levels of depression.

Study limitations and future directions

As a pilot trial, the current study is limited by a small sample size, which is comprised exclusively of individuals with RRMS subtype, as has been common in research to date [8]. The current study did not detect any structural white matter changes in the brain following the exercise intervention; this may be due, in part, to a limited sample size, but could also be influenced by additional factors (e.g., that the intensity or duration of the exercise was insufficient). Future research would benefit from larger samples that also include individuals with progressive forms of MS to help clarify this, as well as determine whether imaging, cognitive, and psychosocial outcomes are influenced by MS subtype. Future studies may also benefit from increasing the intensity of the prescribed aerobic exercise, as tolerated by individuals with MS, in accordance with activity recommendations for individuals with MS [47, 48].

The current pilot study also employed a within-persons pre-post design. As research in this area expands beyond pilot trials, the inclusion of additional control groups (i.e., individuals with MS who resume activity as normal) is needed to determine the extent to which exercise may impact the typical progression of pathological changes that occur in MS.

There are also a number of participant characteristics that may be unique to our participant sample. For example, it is also notable that some of our participants were already fairly active. Future research may choose to selective recruit sedentary participants to assess whether exercise has a greater impact for these individuals. Additionally, the majority of our participants were not cognitively impaired at baseline; many performed at or above the 50th percentile. Thus, future research may wish to specifically recruit individuals with cognitive impairment to better assess the impact of exercise on individuals with cognitive impairment.

Furthermore, the extent to which the observed improvements in fatigue and some aspects of cognition may be long lasting is unclear. It is possible that these improvements may eventually plateau, or otherwise decline across time. Thus, it would be useful for future research to track participants longitudinally over a number of years, with frequent follow-up appointments. Additionally, follow-up studies could use a design that captures change over time prior to the intervention, so this change can be compared to change over the course of the intervention. Importantly, given the traditional focus on physical measures (e.g., walking, strength, mobility) future exercise research trials should consider including frequently observed psychosocial and cognitive symptoms as primary outcome measures. Additionally, given the importance of patient-oriented research, future research studies may benefit from the inclusion of minimal clinically important difference scores, which reflect perceived benefits from the patient [49].

Lastly, although the current study did not detect any structural white matter changes in the brain following the exercise intervention, it did not investigate whether any functional changes in the brain took place or whether there were changes in gray matter. There is preliminary evidence from other pilot trials that exercise interventions have contributed to increased resting state functional connectivity in the thalamo-cortical regions [50]. Thus, future research would benefit from a multi-modal imaging approach that also include functional approaches such as functional MRI. It is notable that DTI may have limited clinical use for tracking the efficacy of exercise interventions for RRMS. Thus, multi-modal research may also further clarify the extent to which DTI is an effective means of tracking the efficacy of exercise interventions for people with RRMS.

Conclusions

Following the implementation of a 12-week walking exercise intervention, individuals with RRMS performed significantly better on a measure of information processing speed, perceived fewer prospective memory problems, and reported fewer problems with fatigue. White matter integrity did not significantly decrease or increase. Together, this suggests that although there is not enough evidence to suggest speeded walking is reparative, 12 weeks of speeded walking holds promise for managing some symptoms for individuals with RRMS. The findings of this study should be interpreted within the context of the study design and limited study population.

Availability of data and materials

The dataset for the current study may be available from the corresponding author on reasonable request.

Abbreviations

MS:

Multiple sclerosis

RRMS:

Relapsing remitting multiple sclerosis

DTI:

Diffusion tensor imaging

SDMT:

Symbol Digits Modalities Test

PDQ:

Perceived Deficits Questionnaire

MFIS:

Modified Fatigue Impact Scale

BDI-II:

Beck Depression Inventory

FA:

Fractional anisotropy

MD:

Mean diffusivity

AD:

Axial diffusivity

RD:

Radial diffusivity

TBSS:

Tract-based spatial statistics

References

  1. 1.

    Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502–17.

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Kister I, Bacon T, Chamot E, Salter AR, Cutter GR, Kalina JT, Herbert J. Natural history of multiple sclerosis symptoms. Int J MS Care. 2013;15:146–70.

    PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    Hartung DM, Bourdette DN, Ahmed S, Whitham RH. The cost of multiple sclerosis drugs in the US and the pharmaceutical industry. Neurology. 2015;84:2185–92.

    PubMed  PubMed Central  Article  Google Scholar 

  4. 4.

    Torkildsen O, Myhr KM, Bo L. Disease-modifying treatments for multiple sclerosis—a review of approved medications. Eur J Neurol. 2016;23:18–27.

    PubMed  Article  Google Scholar 

  5. 5.

    Bherer L, Erickson KI, Liu-Ambrose T. A review of the effects of physical activity and exercise on cognitive and brain functions in older adults. J Aging Res. 2013;2013:1–8.

  6. 6.

    Svensson M, Lexell J, Deierborg T. Effects of physical exercise on neuroinflammation, neuroplasticity, neurodegeneration, and behavior: what we can learn from animal models in clinical settings. Neurorehabil Neural Repair. 2015;29:577–89.

    PubMed  Article  Google Scholar 

  7. 7.

    Jang Y, Koo JH, Kwo I, Kang EB, Um HS, Soya H, Lee Y, Cho JY. Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson’s disease mice. Brain Res. 2017;1655:186–93.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Heine M, van de Port I, Rietberg MB, van Wegen EEH Kwakkel, G. Exercise therapy for fatigue in multiple sclerosis. Cochrane Database Syst Rev. 2015;9:1–125.

    Google Scholar 

  9. 9.

    Rietberg MB, Brooks D, Uitdegaag BM, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database Sys Rev. 2005;25:CD003980.

    Google Scholar 

  10. 10.

    Motl RW, Pilutti LA. The benefits of training in multiple sclerosis. Nature Rev Neurol. 2012;8:487–97.

    Article  Google Scholar 

  11. 11.

    Sandroff BM, Motl RW, Scudder MR, DeLuca J. Systematic, evidence-based review of exercise, physical activity, and physical fitness effects on cognition in persons with multiple sclerosis. Neuropsychol Rev. 2016;26:271–94.

    PubMed  Article  Google Scholar 

  12. 12.

    Pilutti LA, Greenlee TA, Motl RW, Ms N, Petruzzello SJ. Effects of exercise training on fatigue in multiple sclerosis: a meta-analysis. Psychosom Med. 2013;75:575–80.

    CAS  PubMed  Article  Google Scholar 

  13. 13.

    Dalgas U, Stenager E, Sloth M, Stenager E. The effect of exercise on depressive symptoms in multiple sclerosis based on a meta-analysis and critical review of the literature. Eur J Neurol. 2015;22:443–56.

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Giesser BS. Exercise in the management of persons with multiple sclerosis. Ther Adv Neurol Diso. 2015;8:123–30.

    Article  Google Scholar 

  15. 15.

    Motl RW, Sandroff BM. Benefits of exercise training in multiple sclerosis. Curr Neurol Neurosci. 2015;15:1–9.

    Article  Google Scholar 

  16. 16.

    Thompson AJ, Banwell BL, Barkhof F, Carroll WM, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017;17:162–73.

    PubMed  Article  Google Scholar 

  17. 17.

    Leavitt VM, Cirnigliao C, Cohen A, Garag A, Brooks M, Wecht JM, Wylie GR, Chiaravalloti ND, DeLuca J, Sumowski JF. Aerobic exercise increases hippocampal volume and improves memory in multiple sclerosis: preliminary findings. Neurocase. 2014;20:695–7.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Alexander AL, Lee LE, Lazar M, Field AS. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007;4:316–29.

    PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Soares JM, Marques P, Alves V, Sousa N. A hitchhiker’s guide to diffusion tensor imaging. Front Neurosci. 2013;7:1–14.

    Article  Google Scholar 

  20. 20.

    Harrison DM, Caffo BS, Shiee N, Farrell JAD, Bazin PL, Farrell SK, Ratchford JN, Calabresi PA, Reich DS. Longitudinal changes in diffusion tensor-based quantitative MRI in multiple sclerosis. Neurology. 2011;76:179–86.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  21. 21.

    Parmenter BA, Weinstock-Guttman B, Garg N, Munschauer F, Benedict RH. Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test. Mult Scler J. 2007;13:52–7.

    CAS  Article  Google Scholar 

  22. 22.

    Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Ski. 1958;8:271–6.

    Article  Google Scholar 

  23. 23.

    Jensen AR, Figueroa RA. Forward and backward digit span interaction with race and IQ: predictions from Jensen’s theory. J Educ. 1975;67:882–93.

    CAS  Google Scholar 

  24. 24.

    Ritvo PG, Fischer JS, Miller DM, Andrews H, Paty DW, LaRocca NG. MSQLI Forms. In multiple sclerosis quality of life inventory: a user’s manual. 1997. Retrieved from http://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-Researchers/Clinical-Study-Measures/Multiple-Sclerosis-Quality-of-Life-Inventory-(MSQLI)

  25. 25.

    Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994;21:9–14.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100.

    Article  Google Scholar 

  27. 27.

    Sandroff BM, Balto JM, Klaren RE, Sommer SK, DeLuca J, Motl RW. Systematically developed pilot randomized controlled trial for exercise and cognition in persons with multiple sclerosis. Neurocase. 2016;22:443–50.

    PubMed  Article  Google Scholar 

  28. 28.

    Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, Bannister PR, DeLuca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage. 2004;23:S208–19.

    PubMed  Article  Google Scholar 

  29. 29.

    Smith SM. Fast robust automated brain extraction. Human Brain Mapping. 2002;17:143–55.

    PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Zaheer Cader M, Matthews PM, Behrens TEJ. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. NeuroImage. 2006;31:1487–505.

    PubMed  Article  Google Scholar 

  31. 31.

    Lassman H. Multiple sclerosis pathology. Cold Spring Harb Perspect Med. 2018;8:1–15.

    Article  CAS  Google Scholar 

  32. 32.

    Ontaneda D, Sakaie K, Lin J, Wang X, Lowe MJ, Phillips MD, Fox RJ. Measuring brain tissue integrity over 4 years using diffusion tensor imaging. Am J Neuroradiol. 2017;38:31–8.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Kolasa M, Hakulinen U, Brander A, Hagman S, Dastidar P, Elovaara I, Sumelahti M. Diffusion tensor imaging and disability progression in multiple sclerosis: a 4 year follow-up study. Brain Behav. 2019;9:1–10.

  34. 34.

    Tavazzi E, Bergsland N, Cattaneo D, Gervasoni E, Lagana MM, Dipasquale O, Grosso C, Saibene FL, Baglio F, Rovaris M. Effects of motor rehabilitation on mobility and brain plasticity in multiple sclerosis: a structural and functional MRI study. J Neurol. 2018;265:1393–401.

    PubMed  Article  Google Scholar 

  35. 35.

    Benedict RHB, Zivadinov R. Risk factors for and management of cognitive function in multiple sclerosis. Nature Rev Neurol. 2011;7:332–42.

    Article  Google Scholar 

  36. 36.

    Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7:1139–51.

    PubMed  Article  Google Scholar 

  37. 37.

    Planche V, Gibelin M, Cregut D, Pereira B, Clavelou P. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis. Eur J Neurol. 2016;23:282–9.

    CAS  PubMed  Article  Google Scholar 

  38. 38.

    Benedict RHB, De Luca J, Phillips G, LaRocca N, Hudson LD, Rudick R, Multiple Sclerosis Outcome Assessments Consortium. Validity of the Symbol Digit Modalities Test as a cognitive performance outcome measure for multiple sclerosis. Mult Scler J. 2017;23:721–33.

    Article  Google Scholar 

  39. 39.

    Strober L, DeLuca J, Benedict RHB, Jacobs A, Cohen JA, Chiaravalloti N, Hudson LD, Rudick RA, LaRocca NG. Multiple Sclerosis Outcome Assessments Consortium. Symbol Digit Modalities Test: a valid clinical endpoint for measuring cognition in multiple sclerosis. Mult Scler J. 2018;24:1–10.

  40. 40.

    Sangelaji B, Estebsari F, Nabavi SM, Jamshidi E, Morsali D, Dastoorpoor M. The effect of exercise therapy on cognitive functions in multiple sclerosis patients: a pilot study. MJIRI. 2015;29:1–9.

    Google Scholar 

  41. 41.

    Briken S, Gold SM, Patra S, Vettorazzi E, Harbs D, Tallner A, Ketels G, Schultz KH, Heesen C. Effects of exercise on fitness and cognition in progressive MS: a randomized controlled pilot trial. Mult Scler J. 2014;20:382–90.

    CAS  Article  Google Scholar 

  42. 42.

    Asano M, Finlayson ML. Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication. Mult Scler Int. 2014;37:729–38.

    Google Scholar 

  43. 43.

    Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact, and management. Mult Scler J. 2003;9:219–27.

    Article  Google Scholar 

  44. 44.

    Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry. 2005;77:34–9.

    Article  Google Scholar 

  45. 45.

    Feinstein A, Magalhaes S, Richard J, Audet B, Moore C. The link between depression and multiple sclerosis. Nature Rev Neurol. 2014;10:507–17.

    Article  Google Scholar 

  46. 46.

    Koch MW, Patten S, Berzins S, Zhornitski S, Greenfield J, Wall W, Metz LM. Depression in multiple sclerosis: a long-term longitudinal study. Mult Scler J. 2015;21:76–82.

    Article  Google Scholar 

  47. 47.

    Latimer-Cheung AE, Martin Ginis KA, Hicks AL, Motl RW, Pilutti LA, Duggan M, Wheeler G, Persad R, Smith KM. Development of evidence-informed physical activity guidelines for adults with multiple sclerosis. Arch Phys M. 2013;94:1829–36.

    PubMed  Article  Google Scholar 

  48. 48.

    Dalgas U, Stenager E, Ingemann-Hansen T. Multiple Sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combin training. Mult Scler. 2008;14:35–53.

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Cook CE. The minimally clinically important change scores: a necessary pretense. J. Man. Manip. Ther. 2008;16:1–2.

    Article  Google Scholar 

  50. 50.

    Sandroff BM, Wylie GR, Sutton BP, Johnson CL, DeLuca J, Motl RW. Treadmill walking exercise training and brain function in multiple sclerosis: preliminary evidence setting the stage for a network approach to rehabilitation. Mult Scler J. 2018;4:1–5.

    Google Scholar 

Download references

Acknowledgements

We wish to thank the individuals with MS with whom we consulted about this study as well as the individuals with MS who participated in our study. We also wish to thank the BC SUPPORT Unit, especially Dr. Uta Sboto-Frankenstein, Island Health’s Permission to Contact Program Coordinator, Ms. Rebecca Barnes, Branch Out Neurological Foundation Summer Student Trainee, Ms. Colleen Lacey, and West Coast Medical Imaging MRI Technician, Ms. Jody Sydney.

Funding

This work was supported by the Michael Smith Foundation for Health Research and BC SUPPORT Unit Pathway to Patient Oriented Research Award, Canadian Institutes of Health Research Doctoral Research Award, Branch Out Neurological Foundation, and Island Health Student Research Grant Competition.

Author information

Affiliations

Authors

Contributions

CM, LH, KA, LSH, and JG contributed to study conception and design. CM & JG contributed to the data collection and analysis. CM wrote the first draft with other authors providing critical review. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Jodie R. Gawryluk.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the harmonized institutional human research ethics board at the University of Victoria and Island Health.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mayo, C.D., Harrison, L., Attwell-Pope, K. et al. A pilot study of the impact of an exercise intervention on brain structure, cognition, and psychosocial symptoms in individuals with relapsing-remitting multiple sclerosis. Pilot Feasibility Stud 7, 65 (2021). https://doi.org/10.1186/s40814-021-00806-2

Download citation

Keywords

  • Multiple sclerosis
  • Diffusion tensor imaging
  • Exercise
  • Cognition
  • Fatigue
  • Depressed mood
  • Symptom management
\